Plant Proteinase Inhibitor BbCI Modulates Lung Inflammatory Responses and Mechanic and Remodeling Alterations Induced by Elastase in MiceReportar como inadecuado




Plant Proteinase Inhibitor BbCI Modulates Lung Inflammatory Responses and Mechanic and Remodeling Alterations Induced by Elastase in Mice - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BioMed Research International - Volume 2017 2017, Article ID 8287125, 13 pages - https:-doi.org-10.1155-2017-8287125

Research Article

Department of Medicine, School of Medicine, University of São Paulo, São Paulo, SP, Brazil

Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Department of Biochemistry, Federal University of São Paulo, São Paulo, SP, Brazil

Department of Biological Sciences, Federal University of São Paulo, São Paulo, SP, Brazil

The Lovelace Respiratory Research Institute, Albuquerque, NM, USA

Correspondence should be addressed to Iolanda F. L. C. Tibério

Received 18 August 2016; Revised 20 February 2017; Accepted 9 March 2017; Published 30 March 2017

Academic Editor: Anastasia Kotanidou

Copyright © 2017 Rafael Almeida-Reis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. Proteinases play a key role in emphysema. Bauhinia bauhinioides cruzipain inhibitor BbCI is a serine-cysteine proteinase inhibitor. We evaluated BbCI treatment in elastase-induced pulmonary alterations. Methods.  C57BL-6 mice received intratracheal elastase ELA group or saline SAL group. One group of mice was treated with BbCI days 1, 15, and 21 after elastase instillation, ELABC group. Controls received saline and BbCI SALBC group. After 28 days, we evaluated respiratory mechanics, exhaled nitric oxide, and bronchoalveolar lavage fluid. In lung tissue we measured airspace enlargement, quantified neutrophils, TNFα-, MMP-9-, MMP-12-, TIMP-1-, iNOS-, and eNOS-positive cells, 8-iso-PGF2α, collagen, and elastic fibers in alveolar septa and airways. MUC-5-positive cells were quantified only in airways. Results. BbCI reduced elastase-induced changes in pulmonary mechanics, airspace enlargement and elastase-induced increases in total cells, and neutrophils in BALF. BbCI reduced macrophages and neutrophils positive cells in alveolar septa and neutrophils and TNFα-positive cells in airways. BbCI attenuated elastic and collagen fibers, MMP-9- and MMP-12-positive cells, and isoprostane and iNOS-positive cells in alveolar septa and airways. BbCI reduced MUC5ac-positive cells in airways. Conclusions. BbCI improved lung mechanics and reduced lung inflammation and airspace enlargement and increased oxidative stress levels induced by elastase. BbCI may have therapeutic potential in chronic obstructive pulmonary disease.





Autor: Rafael Almeida-Reis, Osmar A. Theodoro-Junior, Bruno T. M. Oliveira, Leandro V. Oliva, Alessandra C. Toledo-Arruda, Camila R.

Fuente: https://www.hindawi.com/



DESCARGAR PDF




Documentos relacionados